Wells Fargo’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.95M Sell
30,300
-12,611
-29% -$1.15M ﹤0.01% 3287
2025
Q4
$5.58M Buy
42,911
+13,985
+48% +$1.92M ﹤0.01% 2574
2025
Q3
$3.12M Buy
28,926
+14,652
+103% +$1.6M ﹤0.01% 2973
2025
Q2
$1.32M Buy
14,274
+606
+4% +$47.6K ﹤0.01% 3515
2025
Q1
$1.21M Buy
13,668
+5,286
+63% +$459K ﹤0.01% 3522
2024
Q4
$644K Buy
8,382
+2,480
+42% +$173K ﹤0.01% 4010
2024
Q3
$250K Buy
5,902
+349
+6% +$11.8K ﹤0.01% 4428
2024
Q2
$145K Buy
5,553
+5,013
+928% +$95K ﹤0.01% 4717
2024
Q1
$4.93K Buy
540
+3
+0.6% +$18 ﹤0.01% 5893
2023
Q4
$1.48K Buy
537
+8
+2% +$19 ﹤0.01% 6147
2023
Q3
$1.93K Buy
529
+4
+0.8% +$22 ﹤0.01% 6099
2023
Q2
$3.13K Sell
525
-1,522
-74% -$12K ﹤0.01% 6155
2023
Q1
$24.7K Buy
2,047
+1,653
+420% +$22K ﹤0.01% 5560
2022
Q4
$3.43K Sell
394
-110
-22% -$2.42K ﹤0.01% 5873
2022
Q3
$14K Buy
504
+388
+334% +$17.8K ﹤0.01% 5555
2022
Q2
$4K Buy
116
+57
+97% +$3.87K ﹤0.01% 6119
2022
Q1
$6K Sell
59
-3
-5% -$333 ﹤0.01% 6433
2021
Q4
$9K Sell
62
-50
-45% -$11.2K ﹤0.01% 6594
2021
Q3
$28K Buy
112
+22
+24% +$7.56K ﹤0.01% 5857
2021
Q2
$41K Sell
90
-35
-28% -$15K ﹤0.01% 5636
2021
Q1
$62K Buy
+125
New +$65K ﹤0.01% 5715

Other funds holding WGS

Wells Fargo's WGS Position: Q1 2026 in Review

Wells Fargo reduced its GeneDx Holdings (WGS) stake by 29% in Q1 2026, selling an estimated $1.15M and leaving 30,300 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #3287.

Wells Fargo first reported a position in WGS in Q1 2021 and has held it in 21 quarters since. The position peaked at $5.58M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Wells Fargo held 30,300 shares of GeneDx Holdings worth $1.95M as of Q1 2026.
  • Wells Fargo sold 12,611 GeneDx Holdings shares in Q1 2026, an estimated $1.15M.
  • GeneDx Holdings made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3287 holding.
  • Wells Fargo first reported a position in GeneDx Holdings in Q1 2021 and has held it in 21 quarters since.
  • Wells Fargo's GeneDx Holdings position peaked at $5.58M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.